Immediate test results and patient treatment reduces the likelihood of a readmission “within 30 days of discharge” that could result in hospital penalties under Accountable Care.
“Consolidates and replaces all tests devices in the market in a single device, eliminating multiple daily trips with blood samples to central labs by testing the patient wherever they are. Our device is smartphone embedded, offering maximum utility through unlimited apps designed for the system. The only device truly suitable for home health care diagnostics”
It’s that time again! Time for the JP Morgan Healthcare meeting. The iAssay team will be at the 38th Annual JP Morgan Healthcare Conference from January 13 to January 15, 2020. We would love to catch up with you. For more information on the meeting, check out https://www.jpmorgan.com/global/healthcareconference . We are interested in talking […]
We will be at the meeting on Wednesday, Thursday, and Friday. We are looking forward to seeing old friends, and making new ones. Please get in touch with our CEO, Lonnie Adelman to setup a time to meet: Lonnie.Adelman@iAssay.net. WhatsApp works for us too. See details on the first handheld, universal point of care device […]
iAssay and Fio Collaborate to Provide HIPAA-Compliant Cloud-based Remote Patient Test and Analytics Reports in Internet Portals, Expanding Access for Point of Care Testing San Diego, Calif. – August 5, 2019 – Virtual healthcare technology providers Fio Corporation and iAssay, Inc are collaborating to support their shared mission to […]
We are excited to announce that once again, iAssay will attending the annual AACC meeting in Anaheim. We’ll be meeting with suppliers (current and potential), investors, and also reagent test cartridge manufacturers interested in partnering with iAssay. iAssay’s patented universal, handheld point of care testing system includes a sophisticated Health IT connection that allows test […]
SAN DIEGO, CA – June 4, 2019 – iAssay® Inc., a privately held developer of the world’s first open platform, point of care (POC) reader for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has granted the company US Patent Number 10,309,954. The granted patent includes 66 claims relating […]
We are pleased to announce that GenomeWeb has published a new article discussing the home healthcare POC space, and how iAssay fits. Click here to see the reprint: iAssay Reprint PDF .
SAN DIEGO, CA – January 29, 2019 – iAssay® Inc., a privately held developer of the world’s first open platform, point of care (POC) reader for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 13/074,209. The allowed patent includes […]